salutedomani.com
-
Showing posts tagged drug
-
FDA approves Ferriprox to treat patients with excess iron in the body
The U.S. Food and Drug Administration approved Ferriprox (deferiprone) to treat patients with iron overload due to blood transfusions in patients with thalassemia, a genetic blood disorder that causes anemia, who had an inadequate response to prior chelation therapy.
-
Halloween, Black Licorice: Trick or Treat?
As it turns out, you really can overdose on candy—or, more precisely, black licorice.
Days before the biggest candy eating holiday of the year, the Food and Drug Administration (FDA) encourages moderation if you enjoy snacking on the old fashioned favorite.
(Source: salutedomani.com)
-
World Stroke Day: one in six people will have a stroke
The theme of this year’s World Stroke Day on 29 October is “One in Six”, referring to the facts that one in six people will have a stroke at some point in their lifetime, and that a stroke will be the cause of someone’s death every six seconds. These, says the World Stroke Organization (WSO), are everyday people leading everyday lives, but around 85% of them will have risk factors which, if identified, are preventable.
-
FDA invests $2 million in partnerships through Centers of Excellence in Regulatory Science and Innovation
The U.S. Food and Drug Administration today announced the award of $2 million to support two regional Centers of Excellence in Regulatory Science and Innovation (CERSI).
-
AACR Calls for Letters of Intent for a Stand Up To Cancer-Prostate Cancer Foundation Dream Team
Stand Up To Cancer (SU2C) and the Prostate Cancer Foundation (PCF), along with the American Association for Cancer Research, call upon the cancer research community to submit Letters of Intent for a new Dream Team dedicated to prostate cancer research.
(Source: salutedomani.com)
-
FDA approves Xarelto to prevent stroke in people with common type of abnormal heart rhythm
The U.S. Food and Drug Administration approved the anti-clotting drug Xarelto (rivaroxaban) to reduce the risk of stroke in people who have abnormal heart rhythm (non-valvular atrial fibrillation). Atrial fibrillation occurs in more than 2 million Americans and is one of the most common types of abnormal heart rhythm.
-
FDA approves Eylea* (aflibercept) for eye disorder in older people
The U.S. Food and Drug Administration approved Eylea (aflibercept) to treat patients with wet (neovascular) age-related macular degeneration (AMD), a leading cause of vision loss and blindness in Americans ages 60 and older.
-
FDA approves first generic version of cholesterol-lowering drug Lipitor
The U.S. Food and Drug Administration approved the first generic version of the cholesterol-lowering drug Lipitor (atorvastatin calcium tablets).
-
FDA approves two new pancreatic enzyme products to aid food digestion (Ultresa* - Viokace*)
Two new pancreatic enzyme products used to help aid food digestion, Ultresa (pancrelipase) and Viokace (pancrelipase), were approved by the U.S. Food and Drug Administration.
